Purpose
Positron emission tomography (PET) has been suggested as an imaging
technique for in vivo proton dose and range verification
after proton induced-tissue activation. During proton treatment, irradiated
tissue is activated and decays while emitting positrons. In this paper, we
assessed the feasibility of using PET imaging after proton treatment to
determine tissue elemental composition by evaluating the resultant composite
decay curve of activated tissue.
Methods
A phantom consisting of sections composed of different combinations
of 1H, 12C, 14N, and 16O was
irradiated using a pristine Bragg peak and a 6-cm spread-out Bragg-peak
(SOBP) proton beam. The beam ranges defined at 90% distal dose were
10 cm; the delivered dose was 1.6 Gy for the near monoenergetic beam and 2
Gy for the SOBP beam. After irradiation, activated phantom decay was
measured using an in-room PET scanner for 30 minutes in list mode. Decay
curves from the activated 12C and 16O sections were
first decomposed into multiple simple exponential decay curves, each curve
corresponding to a constituent radioisotope, using a least-squares method.
The relative radioisotope fractions from each section were determined. These
fractions were used to guide the decay curve decomposition from the section
consisting mainly of 12C+16O and calculate the
relative elemental composition of 12C and 16O. A Monte
Carlo simulation was also used to determine the elemental composition of the
12C + 16O section. The calculated compositions of
the 12C + 16O section using both approaches (PET and
Monte Carlo) were compared with the true known phantom composition. Finally,
2 patients were imaged using an in-room PET scanner after proton therapy of
the head. Their PET data and the technique described above were used to
construct elemental composition (12C and 16O) maps
that corresponded to the proton-activated regions. We compared the
12C and 16O compositions of 7 ROIs that
corresponded to the vitreous humor, adipose/face mask, adipose tissue, and
brain tissue with ICRU 46 elemental composition data.
Results
The 12C and 16O compositions of the
12C + 16O phantom section were estimated to within
a maximum difference of 3.6% for the near monoenergetic and SOBP
beams over an 8-cm depth range. On the other hand, the Monte Carlo
simulation estimated the corresponding 12C and 16O
compositions in the 12C + 16O section to within a
maximum difference of 3.4%. For the patients, the 12C and
16O compositions in the 7 ROIs agreed with the ICRU elemental
composition data, with a mean (maximum) difference of 9.4%
(15.2%).
Conclusions
The 12C and 16O compositions of the phantom and
patients were estimated with relatively small differences. PET imaging may
be useful for determining the tissue elemental composition and theeby
improving proton treatment planning and verification.